Cardiac biomarkers are highly prognostic of in‑hospital mortality in patients with COVID‑19: what is the effect of renin angiotensin system blockers without baseline heart failure on these biomarkers? [0.03%]
心脏生物标志物是COVID-19患者院内死亡率的强力预测指标：无心力衰竭病史的患者的肾素血管紧张素系统阻滞剂对这些生物标志物有何影响？
Dimitrios Patoulias
Dimitrios Patoulias
Cardiac biomarkers are highly prognostic of in‑hospital mortality in patients with COVID‑19: what is the effect of renin angiotensin system blockers without baseline heart failure on these biomarkers? Authors' reply [0.03%]
心脏生物标志物可高度预测COVID-19患者的院内死亡率：无心力衰竭基线的肾素血管紧张素系统阻滞剂对这些生物标志物有什么影响？作者回复
Marek Klocek,Michał Terlecki,Wiktoria Wojciechowska et al.
Marek Klocek et al.
Neuropsychiatric manifestations and their attribution to systemic lupus erythematosus: a retrospective single-center study in a Polish population [0.03%]
波兰人群中的神经精神症状及其系统性红斑狼疮的病因：一家医学中心的回顾性研究
Katarzyna Pawlak-Buś,Wiktor Schmidt,Piotr Leszczyński
Katarzyna Pawlak-Buś
Introduction: Neuropsychiatric (NP) manifestations occur in patients with systemic lupus erythematosus (SLE), and it is challenging to distinguish these manifestations from other neuropsychiatric conditions. ...
Dynamic changes in soluble suppression of tumorigenicity 2 levels predict major adverse cardiovascular events in patients with ST‑segment elevation myocardial infarction [0.03%]
心肌梗死溶栓治疗患者中可溶性抑瘤基因产物2水平的动态变化可预测不良心血管事件的发生
Lei Liu,Shengyu Li,Xiaosong Ding et al.
Lei Liu et al.
Introduction：The predictive value of soluble suppression of tumorigenicity 2 (sST2) for the occurrence of major adverse cardiovascular events (MACEs) in patients with ST‑segment elevation myocardial infarction (STEMI) remains unclear. ...
Ecthyma gangrenosum as the primary manifestation of acute myeloid leukemia in a previously healthy patient [0.03%]
急性髓系白血病的首发表现为坏疽性荨麻疹型瘭疽(既往身体健康患者)
Georgia Kaiafa,Stylianos Daios,Stavroula Bountola et al.
Georgia Kaiafa et al.
Changes in osteoporosis therapy in postmenopausal women from the RAC‑OST‑POL study: a 10‑year follow‑up [0.03%]
波兰绝经后妇女骨质疏松症治疗的改变：RAC-OST-POL研究的10年随访结果
Wojciech Pluskiewicz,Piotr Adamczyk,Bogna Drozdzowska
Wojciech Pluskiewicz
Introduction: Therapeutic regimens for osteoporosis are the key elements in the management of osteoporotic patients. Objective: The aim...
Revascularization in patients with ST‑segment elevation myocardial infarction and multivessel coronary artery disease: preliminary results from a large multicenter national registry [0.03%]
肌钙蛋白超高水平急性冠脉综合征患者经皮冠状动脉介入治疗的临床预后分析：来自中国当代经皮冠状动脉介入治疗注册登记研究的数据
Marcin Sadowski,Krzysztof Milewski,Łukasz Zandecki et al.
Marcin Sadowski et al.
Multicenter Study
Polish archives of internal medicine. 2022 Sep 26;132(9):16315. DOI:10.20452/pamw.16315 2022
A series of Polish patients with congenital fibrinogen disorders: 2 new mutations in fibrinogen gamma chain, Fibrinogen Kostrzyn and Fibrinogen Łódź II [0.03%]
一系列波兰先天性纤维蛋白原紊乱患者的资料：纤维蛋白原Kostrzyn和纤维蛋白原Lodz II两新γ链突变
Anna Weronska,Anna Klukowska,Marguerite Neerman-Arbez et al.
Anna Weronska et al.
Clinical characteristics and antiviral therapy in patients infected with hepatitis C virus in the interferon‑free era [0.03%]
干扰素-free时代丙型肝炎病毒感染患者的临床特征和抗病毒治疗状况分析
Michał Brzdęk,Krystyna Dobrowolska,Paweł Pabjan et al.
Michał Brzdęk et al.
Introduction: The highly effective and safe interferon (IFN)-free options were a breakthrough in the treatment of patients infected with hepatitis C virus (HCV). ...
Combined large-cell neuroendocrine carcinoma and atypical carcinoid of the thymus presenting as ectopic Cushing syndrome [0.03%]
以异位库欣综合征表现为胸腺类癌和大细胞神经内分泌癌联合型一例报告
Adam Maciejewski,Paweł Gut,Piotr Stajgis et al.
Adam Maciejewski et al.